UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetically Engineered Mouse Models in Cancer Research

Advances in Cancer Research, 2010, Vol.106, p.113-164

2010

Volltextzugriff (PDF)

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Clinical cancer research, 2013-09, Vol.19 (17), p.4559-4563

2013

Volltextzugriff (PDF)

Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations

Frontiers in chemistry, 2021-01, Vol.8, p.622632

2021

Volltextzugriff (PDF)

Galanin Protects Against Behavioral and Neurochemical Correlates of Opiate Reward

Neuropsychopharmacology (New York, N.Y.), 2008-07, Vol.33 (8), p.1864-1873

2008

Volltextzugriff (PDF)

Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury

Current protocols, 2022-07, Vol.2 (7), p.e478-n/a

2022

Volltextzugriff (PDF)

Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies

Neuro-oncology (Charlottesville, Va.), 2011-06, Vol.13 (6), p.610-621

2011

Volltextzugriff (PDF)

Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain

Journal of comparative neurology (1911), 2004-11, Vol.479 (4), p.410-423

2004

Volltextzugriff (PDF)

Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis

Toxicologic pathology, 2010-01, Vol.38 (1), p.123-130

2010

Volltextzugriff (PDF)

Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase

The European journal of neuroscience, 2006-06, Vol.23 (11), p.2937-2946

2006

Volltextzugriff (PDF)

The Neuropeptide Galanin Modulates Behavioral and Neurochemical Signs of Opiate Withdrawal

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (15), p.9028-9033

2003

Volltextzugriff (PDF)

Nf1 expression is dependent on strain background : implications for tumor suppressor haploinsufficiency studies

Neurogenetics, 2007-04, Vol.8 (2), p.121-130

2007

Volltextzugriff (PDF)

GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP‐dependent mechanism

Journal of neurochemistry, 2005-06, Vol.93 (5), p.1168-1176

2005

Volltextzugriff (PDF)

Galanin attenuates cyclic AMP regulatory element‐binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures

Journal of neurochemistry, 2006-02, Vol.96 (4), p.1160-1168

2006

Volltextzugriff (PDF)

Tandem mass spectrometric sequence characterization of synthetic thymidine‐rich oligonucleotides

Journal of mass spectrometry., 2022-04, Vol.57 (4), p.e4819-n/a

2022

Volltextzugriff (PDF)

Decoding Complexity in Synthetic Oligonucleotides: Unraveling Coeluting Isobaric Impurity Ions by High Resolution Mass Spectrometry

Analytical chemistry (Washington), 2024-01, Vol.96 (2), p.904-909

2024

Volltextzugriff (PDF)

Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds

Journal of biomolecular screening, 2008-09, Vol.13 (8), p.795-803

2008

Volltextzugriff (PDF)

Development and Regulatory Challenges for Peptide Therapeutics

International journal of toxicology, 2021-03, Vol.40 (2), p.108-124

2021

Volltextzugriff (PDF)

US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers

Biomarkers in medicine, 2023-06, Vol.17 (11), p.523-531

2023

Volltextzugriff (PDF)

Galanin can attenuate opiate reinforcement and withdrawal

Neuropeptides (Edinburgh), 2005-06, Vol.39 (3), p.313-315

2005

Volltextzugriff (PDF)

The Docking Protein FRS2α Controls a MAP Kinase-Mediated Negative Feedback Mechanism for Signaling by FGF Receptors

Molecular cell, 2002-10, Vol.10 (4), p.709-719

2002

Volltextzugriff (PDF)

Abstract 4893: EGFR signaling controls the chromatin binding status of BMI1 through a CK2/PP1 phosphorylation/dephosphorylation pathway and affects astrocytoma proliferation and neural stem cell differentiation

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4893-4893

2010

Volltextzugriff (PDF)

Abstract 354: PI-103 and TCN as proliferative inhibitors of the RTK/PI3K/ATK signaling pathways in astrocytomas

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.354-354

2010

Volltextzugriff (PDF)

Abstract C12: EGFR signaling controls the chromatin binding status of BMI1 through a CK2/PP1 phosphorylation/dephosphorylation pathway and affects astrocytoma proliferation and neural stem cell differentiation

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23_Supplement), p.C12-C12

2009

Volltextzugriff (PDF)

The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors

Molecular cell, 2002-10, Vol.10 (4), p.709-719

2002

Volltextzugriff (PDF)

Galanin and opiate addiction

Hawes, Jessica Johnson

2005

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetically Engineered Mouse Models in Cancer Research

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations

Galanin Protects Against Behavioral and Neurochemical Correlates of Opiate Reward

Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury

Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies

Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain

Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis

Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase

The Neuropeptide Galanin Modulates Behavioral and Neurochemical Signs of Opiate Withdrawal

Nf1 expression is dependent on strain background : implications for tumor suppressor haploinsufficiency studies

GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP‐dependent mechanism

Galanin attenuates cyclic AMP regulatory element‐binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures

Tandem mass spectrometric sequence characterization of synthetic thymidine‐rich oligonucleotides

Decoding Complexity in Synthetic Oligonucleotides: Unraveling Coeluting Isobaric Impurity Ions by High Resolution Mass Spectrometry

Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds

Development and Regulatory Challenges for Peptide Therapeutics

US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers

Galanin can attenuate opiate reinforcement and withdrawal

The Docking Protein FRS2α Controls a MAP Kinase-Mediated Negative Feedback Mechanism for Signaling by FGF Receptors

Abstract 4893: EGFR signaling controls the chromatin binding status of BMI1 through a CK2/PP1 phosphorylation/dephosphorylation pathway and affects astrocytoma proliferation and neural stem cell differentiation

Abstract 354: PI-103 and TCN as proliferative inhibitors of the RTK/PI3K/ATK signaling pathways in astrocytomas

Abstract C12: EGFR signaling controls the chromatin binding status of BMI1 through a CK2/PP1 phosphorylation/dephosphorylation pathway and affects astrocytoma proliferation and neural stem cell differentiation

The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors

Galanin and opiate addiction

Suchergebnisse filtern